This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Unforeseen situations can impact your financial stability. Explore effective budgeting ways to ensure you are always prepared.
10,042 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
NVIDIA CEO Jensen Huang predicts AI agents will infiltrate every function in every company, signaling a new phase for...
In a market rotating away from fast-growing tech, three dividend aristocrat stocks that have raised payouts for decad...
CF Industries has surged this year on supply constraints and cost advantages, yet a DOJ probe adds regulatory risk th...
Timing matters for Required Minimum Distributions. Learn practical strategies to decide when to take your RMDs, how t...
As AI workloads surge, hyperscalers turn to ASICs to cut costs. This deep dive compares Broadcom and Marvell, explain...
What would it take for a single stock to reach a $2 trillion value in seven years? This article breaks down the drive...
When the market rattles, some stocks prove more durable than others. This guide highlights two steady performers and ...
A new wave in AI infrastructure is building: the million-XPU data center. This article explains what it is, why it ma...
The median age for first-time buyers climbed to a record 40, with Zillow’s chief executive warning relief from high c...
SoFi stock faces a controversial short-seller narrative. This guide explains what that means, how to evaluate the cla...
Bluesky is carving a new path in social media by using an open, federated protocol. This article explains what Bluesk...